Glucose limitation alters glutamine metabolism in MUC1- overexpressing pancreatic cancer cells

Teklab Gebregiworgis, Vinee Purohit, Surendra K. Shukla, Saber Tadros, Nina V. Chaika, Jaime Abrego, Scott E. Mulder, Venugopal Gunda, Pankaj Singh, Robert Powers

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Pancreatic cancer cells overexpressing Mucin 1 (MUC1) rely on aerobic glycolysis and, correspondingly, are dependent on glucose for survival. Our NMR metabolomics comparative analysis of control (S2-013.Neo) and MUC1-overexpressing (S2-013.MUC1) cells demonstrates that MUC1 reprograms glutamine metabolism upon glucose limitation. The observed alteration in glutamine metabolism under glucose limitation was accompanied by a relative decrease in the proliferation of MUC1-overexpressing cells compared with steady-state conditions. Moreover, glucose limitation induces G1 phase arrest where S2-013.MUC1 cells fail to enter S phase and synthesize DNA because of a significant disruption in pyrimidine nucleotide biosynthesis. Our metabolomics analysis indicates that glutamine is the major source of oxaloacetate in S2-013.Neo and S2-013.MUC1 cells, where oxaloacetate is converted to aspartate, an important metabolite for pyrimidine nucleotide biosynthesis. However, glucose limitation impedes the flow of glutamine carbons into the pyrimidine nucleotide rings and instead leads to a significant accumulation of glutamine-derived aspartate in S2-013.MUC1 cells.

Original languageEnglish (US)
Pages (from-to)3536-3546
Number of pages11
JournalJournal of Proteome Research
Volume16
Issue number10
DOIs
StatePublished - Oct 6 2017

Fingerprint

Mucin-1
Glutamine
Pancreatic Neoplasms
Metabolism
Pyrimidine Nucleotides
Cells
Glucose
Oxaloacetic Acid
Biosynthesis
Metabolomics
Aspartic Acid
Metabolites
G1 Phase
Glycolysis
S Phase
Carbon
Nuclear magnetic resonance
DNA

Keywords

  • Cancer metabolism
  • Glucose limitation
  • Glutamine metabolism
  • MUC1 overexpression
  • NMR metabolomics

ASJC Scopus subject areas

  • Biochemistry
  • Chemistry(all)

Cite this

Glucose limitation alters glutamine metabolism in MUC1- overexpressing pancreatic cancer cells. / Gebregiworgis, Teklab; Purohit, Vinee; Shukla, Surendra K.; Tadros, Saber; Chaika, Nina V.; Abrego, Jaime; Mulder, Scott E.; Gunda, Venugopal; Singh, Pankaj; Powers, Robert.

In: Journal of Proteome Research, Vol. 16, No. 10, 06.10.2017, p. 3536-3546.

Research output: Contribution to journalArticle

Gebregiworgis, T, Purohit, V, Shukla, SK, Tadros, S, Chaika, NV, Abrego, J, Mulder, SE, Gunda, V, Singh, P & Powers, R 2017, 'Glucose limitation alters glutamine metabolism in MUC1- overexpressing pancreatic cancer cells', Journal of Proteome Research, vol. 16, no. 10, pp. 3536-3546. https://doi.org/10.1021/acs.jproteome.7b00246
Gebregiworgis, Teklab ; Purohit, Vinee ; Shukla, Surendra K. ; Tadros, Saber ; Chaika, Nina V. ; Abrego, Jaime ; Mulder, Scott E. ; Gunda, Venugopal ; Singh, Pankaj ; Powers, Robert. / Glucose limitation alters glutamine metabolism in MUC1- overexpressing pancreatic cancer cells. In: Journal of Proteome Research. 2017 ; Vol. 16, No. 10. pp. 3536-3546.
@article{b56719ff37204a09987eb25ce0908bd7,
title = "Glucose limitation alters glutamine metabolism in MUC1- overexpressing pancreatic cancer cells",
abstract = "Pancreatic cancer cells overexpressing Mucin 1 (MUC1) rely on aerobic glycolysis and, correspondingly, are dependent on glucose for survival. Our NMR metabolomics comparative analysis of control (S2-013.Neo) and MUC1-overexpressing (S2-013.MUC1) cells demonstrates that MUC1 reprograms glutamine metabolism upon glucose limitation. The observed alteration in glutamine metabolism under glucose limitation was accompanied by a relative decrease in the proliferation of MUC1-overexpressing cells compared with steady-state conditions. Moreover, glucose limitation induces G1 phase arrest where S2-013.MUC1 cells fail to enter S phase and synthesize DNA because of a significant disruption in pyrimidine nucleotide biosynthesis. Our metabolomics analysis indicates that glutamine is the major source of oxaloacetate in S2-013.Neo and S2-013.MUC1 cells, where oxaloacetate is converted to aspartate, an important metabolite for pyrimidine nucleotide biosynthesis. However, glucose limitation impedes the flow of glutamine carbons into the pyrimidine nucleotide rings and instead leads to a significant accumulation of glutamine-derived aspartate in S2-013.MUC1 cells.",
keywords = "Cancer metabolism, Glucose limitation, Glutamine metabolism, MUC1 overexpression, NMR metabolomics",
author = "Teklab Gebregiworgis and Vinee Purohit and Shukla, {Surendra K.} and Saber Tadros and Chaika, {Nina V.} and Jaime Abrego and Mulder, {Scott E.} and Venugopal Gunda and Pankaj Singh and Robert Powers",
year = "2017",
month = "10",
day = "6",
doi = "10.1021/acs.jproteome.7b00246",
language = "English (US)",
volume = "16",
pages = "3536--3546",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - Glucose limitation alters glutamine metabolism in MUC1- overexpressing pancreatic cancer cells

AU - Gebregiworgis, Teklab

AU - Purohit, Vinee

AU - Shukla, Surendra K.

AU - Tadros, Saber

AU - Chaika, Nina V.

AU - Abrego, Jaime

AU - Mulder, Scott E.

AU - Gunda, Venugopal

AU - Singh, Pankaj

AU - Powers, Robert

PY - 2017/10/6

Y1 - 2017/10/6

N2 - Pancreatic cancer cells overexpressing Mucin 1 (MUC1) rely on aerobic glycolysis and, correspondingly, are dependent on glucose for survival. Our NMR metabolomics comparative analysis of control (S2-013.Neo) and MUC1-overexpressing (S2-013.MUC1) cells demonstrates that MUC1 reprograms glutamine metabolism upon glucose limitation. The observed alteration in glutamine metabolism under glucose limitation was accompanied by a relative decrease in the proliferation of MUC1-overexpressing cells compared with steady-state conditions. Moreover, glucose limitation induces G1 phase arrest where S2-013.MUC1 cells fail to enter S phase and synthesize DNA because of a significant disruption in pyrimidine nucleotide biosynthesis. Our metabolomics analysis indicates that glutamine is the major source of oxaloacetate in S2-013.Neo and S2-013.MUC1 cells, where oxaloacetate is converted to aspartate, an important metabolite for pyrimidine nucleotide biosynthesis. However, glucose limitation impedes the flow of glutamine carbons into the pyrimidine nucleotide rings and instead leads to a significant accumulation of glutamine-derived aspartate in S2-013.MUC1 cells.

AB - Pancreatic cancer cells overexpressing Mucin 1 (MUC1) rely on aerobic glycolysis and, correspondingly, are dependent on glucose for survival. Our NMR metabolomics comparative analysis of control (S2-013.Neo) and MUC1-overexpressing (S2-013.MUC1) cells demonstrates that MUC1 reprograms glutamine metabolism upon glucose limitation. The observed alteration in glutamine metabolism under glucose limitation was accompanied by a relative decrease in the proliferation of MUC1-overexpressing cells compared with steady-state conditions. Moreover, glucose limitation induces G1 phase arrest where S2-013.MUC1 cells fail to enter S phase and synthesize DNA because of a significant disruption in pyrimidine nucleotide biosynthesis. Our metabolomics analysis indicates that glutamine is the major source of oxaloacetate in S2-013.Neo and S2-013.MUC1 cells, where oxaloacetate is converted to aspartate, an important metabolite for pyrimidine nucleotide biosynthesis. However, glucose limitation impedes the flow of glutamine carbons into the pyrimidine nucleotide rings and instead leads to a significant accumulation of glutamine-derived aspartate in S2-013.MUC1 cells.

KW - Cancer metabolism

KW - Glucose limitation

KW - Glutamine metabolism

KW - MUC1 overexpression

KW - NMR metabolomics

UR - http://www.scopus.com/inward/record.url?scp=85042187030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042187030&partnerID=8YFLogxK

U2 - 10.1021/acs.jproteome.7b00246

DO - 10.1021/acs.jproteome.7b00246

M3 - Article

VL - 16

SP - 3536

EP - 3546

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 10

ER -